World Pain Relieving Drug Market 2013-2023

Visiongain
July 24, 2013
257 Pages - SKU: VSG5113967
Cameroon Pharmaceuticals and Healthcare Report Q2 2015
2/11/2015 | published by: Business Monitor International
Cameroon Pharmaceuticals and Healthcare Report Q2 2015 BMI View: Rapid population growth and economic development will drive Cameroon's pharmaceuticaland healthcare market expansion over a multi-quarter timeframe, albeit from a low per capita spendinglevel. The combination of  |  read more...
USD 1,295
Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Ocular Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Ocular Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Ocular Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Tension -Type Headache-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Tension -Type Headache-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Tension -Type Headache-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
New Zealand Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: Business Monitor International
New Zealand Pharmaceuticals and Healthcare Report Q2 2015 BMI View: Despite policy initiatives designed to increase the pace of generic penetration, high latentdemand for branded pharmaceuticals will continue to be underpinned by New Zealand's ageing andexpanding  |  read more...
USD 1,295
Colombia Pharmaceuticals and Healthcare Report Q2 2015
2/11/2015 | published by: Business Monitor International
Colombia Pharmaceuticals and Healthcare Report Q2 2015 BMI View: President Juan Manuel Santos continues to push forward healthcare reform for medicine pricecontrols and regulatory reformation. Though, such reforms still leave scepticism as Colombia's strugglingeconomy and expanding  |  read more...
USD 1,295
Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
 

SELECT A LICENSE

    Electronic Access
Single User Fulfilled By Publisher
  USD 2,752  
    Electronic Access
Departmental 1-5 Users
  USD 4,858  
    Electronic Access
Global Site License Fulfilled by Publisher
  USD 11,688  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!